Anaptysbio, Inc SEC filings ANAB
Anaptysbio, Inc has 725 filings in SEC EDGAR's recent list, going back to Jul 6, 2006. Its latest annual report, Form 10-KT, was filed on Sep 21, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 12, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 21, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| 424B5 | Prospectus supplement | Nov 15, 2024 | — |
| S-3 | Shelf registration | Nov 5, 2024 | — |
| 424B5 | Prospectus supplement | Aug 14, 2024 | — |
| S-8 | Employee stock plan registration | Aug 5, 2024 | — |
| S-8 | Employee stock plan registration | Mar 11, 2024 | — |
| S-8 | Employee stock plan registration | Mar 1, 2023 | — |
| 424B5 | Prospectus supplement | Nov 8, 2022 | — |
| S-8 | Employee stock plan registration | Mar 7, 2022 | — |
| S-3 | Shelf registration | Dec 30, 2021 | — |
| S-8 | Employee stock plan registration | Feb 25, 2021 | — |
| S-8 | Employee stock plan registration | Mar 2, 2020 | — |
| S-8 | Employee stock plan registration | Feb 28, 2019 | — |
| 424B5 | Prospectus supplement | Sep 26, 2018 | — |
| 424B5 | Prospectus supplement | Sep 24, 2018 | — |
| S-8 | Employee stock plan registration | Mar 5, 2018 | — |
| S-3ASR | Automatic shelf registration | Feb 5, 2018 | — |
| 424B4 | Prospectus | Oct 13, 2017 | — |
| S-1/A | Amended registration statement | Oct 11, 2017 | — |
| S-1 | Registration statement | Oct 10, 2017 | — |
| 424B4 | Prospectus | Jan 26, 2017 | — |
| S-8 | Employee stock plan registration | Jan 26, 2017 | — |
| S-1/A | Amended registration statement | Jan 17, 2017 | — |
| S-1/A | Amended registration statement | Dec 28, 2016 | — |
| S-1/A | Amended registration statement | Nov 15, 2016 | — |
| S-1/A | Amended registration statement | Aug 19, 2016 | — |
| S-1/A | Amended registration statement | May 10, 2016 | — |
| S-1/A | Amended registration statement | Feb 16, 2016 | — |
| S-1/A | Amended registration statement | Dec 23, 2015 | — |
| S-1 | Registration statement | Sep 9, 2015 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANAB (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1370053
- Former names
- ANAPTYSBIO INC (until Jun 12, 2019); ANAPTYS BIOSCIENCES INC (until Nov 20, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.